Methyl (3R,8Z,19E,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-22-[3-[(E)-3-methylpent-2-enoxy]-3-oxopropyl]-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-2(6),5(26),8,10,12,15,17,19-octaene-3-carboxylate
C41H50N4O5 — CID 155926586
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (3R,8Z,19E,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-22-[3-[(E)-3-methylpent-2-enoxy]-3-oxopropyl]-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-2(6),5(26),8,10,12,15,17,19-octaene-3-carboxylate
Methyl (3R,8Z,19E,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-22-[3-[(E)-3-methylpent-2-enoxy]-3-oxopropyl]-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-2(6),5(26),8,10,12,15,17,19-octaene-3-carboxylate (PubChem CID 155926586) has the molecular formula C41H50N4O5 and a molecular weight of 678.87 g/mol. Its IUPAC name is methyl (3R,8Z,19E,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-22-[3-[(E)-3-methylpent-2-enoxy]-3-oxopropyl]-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-2(6),5(26),8,10,12,15,17,19-octaene-3-carboxylate.
Molecular Properties
| Compound Name | Methyl (3R,8Z,19E,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-22-[3-[(E)-3-methylpent-2-enoxy]-3-oxopropyl]-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-2(6),5(26),8,10,12,15,17,19-octaene-3-carboxylate |
|---|---|
| PubChem CID | 155926586 |
| Molecular Formula | C41H50N4O5 |
| Molecular Weight | 678.87 g/mol |
| Exact Mass | 678.38 |
| IUPAC Name | methyl (3R,8Z,19E,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-22-[3-[(E)-3-methylpent-2-enoxy]-3-oxopropyl]-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-2(6),5(26),8,10,12,15,17,19-octaene-3-carboxylate |
| SMILES | C=Cc1c2[nH]c(c1C)/C=C1\NC(C3=c4[nH]/c(c(C)c4C(=O)[C@@H]3C(=O)OC)=C\c3[nH]c(c(C)c3CC)C2)[C@@H](CCC(=O)OC/C=C(\C)CC)[C@@H]1C |
| InChI | InChI=1S/C41H50N4O5/c1-10-20(4)15-16-50-34(46)14-13-27-23(7)30-17-28-21(5)25(11-2)32(42-28)18-29-22(6)26(12-3)33(43-29)19-31-24(8)35-39(45-31)36(38(27)44-30)37(40(35)47)41(48)49-9/h11,15,17,19,23,27,37-38,42-45H,2,10,12-14,16,18H2,1,3-9H3/b20-15+,30-17-,31-19-/t23-,27-,37+,38?/m0/s1 |
| InChIKey | SIGJTMNXKULBRL-XRMATNPWSA-N |
| XLogP | 5.62 |
| TPSA | 129.07 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 678.87 |
| LogP ≤ 5 | 5.62 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155926586 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.